姬芳玲
Associate Professor Supervisor of Doctorate Candidates Supervisor of Master's Candidates
Gender:Female
Alma Mater:大连理工大学
Degree:Doctoral Degree
School/Department:生物工程学院
Discipline:Bioengineering
Business Address:生物工程学院547房间
E-Mail:fanglingji@dlut.edu.cn
Hits:
Indexed by:期刊论文
Date of Publication:2016-08-01
Journal:BIOMEDICINE & PHARMACOTHERAPY
Included Journals:SCIE、PubMed、Scopus
Volume:82
Page Number:693-703
ISSN No.:0753-3322
Key Words:Chrysin, 5-(2 '-amino) phenyl-7-cyclohexanemethylchrysin (Ch-1); 10-Hydroxy camptothecin; DNA intercalator; Apoptosis; Synergy
Abstract:Chrysin, one of natural flavonoid compounds, has recently been found to possess anti-inflammatory, antiallergic and anticancer properties. To increase its anticancer effects, 5 chrysin derivates were synthesized on the base of DNA intercalator structure. The inhibiting effects of chrysin and its derivatives on cancer cells Hela, BGC823, MCF-7, HepG2, and normal cells HEK-293, were evaluated by MTT assays. 5-(2'-amino) phenyl-7-cyclohexanemethylchrysin (Ch-1), a unique chrysin derivate, killed all the cancer cells but kept above 60% survival rate in normal cells HEK-293 at 62.5 mu M. Treated with chrysin from 250 mM to 500 mM, those cells were still maintained above 60% survival rate. The result of circular dichroism spectra showed that Ch-1 could intercalate DNA while chrysin had no effects on DNA. Interestingly, Hela cells survival rates were 95% and 10%, after treated with 20 mM and 30 mM of Ch-1, respectively. Both intrinsic and extrinsic apoptotic pathway were identified in regulating the cell death caused by Ch-1 in Hela cells. p53, the upstream regulator of apoptotic pathway were extremely significantly up-regulated in Hela cells treated with 25 mM Ch-1. Moreover, the inhibiting effects and apoptotic related proteins responses to Ch-1 on Hela cells were abolished after pre-treated with Pifithrin-alpha (Pft-alpha), a p53 inhibitor. So, p53-depedent apoptosis is the crucial factor governing the inhibiting effects of Ch-1 in Hela cells. Amazingly, Ch-1 at non-toxic concentration (2.5-10 mu M) enhanced significantly anti-cancer effect of 10-hydroxy camptothecin (HCPT) on Hela, BGC823, and MCF-7 cells. (C) 2016 Elsevier Masson SAS. All rights reserved.
诚邀有志于探索生命科学前沿的优秀学子,携手推动相关领域的科学研究与创新!
本团队现面向对生物工程、生物医用材料、免疫学、生物信息学、生物学及医学研究等领域感兴趣、热爱科学研究的同学,招收硕士和博士研究生。
姬芳玲,工学博士,副教授,博士生导师,国际磁共振学会会员,美国化学会ACS会员,中国生物材料学会血液净化材料分会委员。研究方向为重大疾病(自身免疫性疾病)发生发展机制、(纳米)抗体的结构与功能、淋巴细胞分离及细胞异质性研究。主持国家自然科学基金2项,省部级基金1项,参加国家重点项目1项。研究成果发表在Angew. Chem.、Analytical Chemistry、Acta Biomaterialia 及Bioconjugate Chemistry等国际一流期刊。已授权中国发明专利3项。
2006年本科毕业于大连理工大学,获生物工程工学学士学位。2013年研究生毕业于大连理工大学,获生物化工工学博士学位。攻读博士学位期间,获得国家留学基金委资助,前往美国匹兹堡大学医学部结构生物学系进行博士联合培养,联合培养博士导师:美国国家科学院院士、英国皇家化学学会会士Angela M. Gronenborn 教授。2013年12月入职大连理工大学生命科学与技术学院。荣获2020年全国高校生命科学类微课教学比赛三等奖。辽宁省普通高等教育(本科)教学成果奖二等奖(排名第六)、大连理工大学优秀教育教学成果一等奖(排名第六)。2022年入选辽宁省首届优秀研究生导师团队成员。主译并由高等教育出版社出版Damien Nevoltris和Patrick Chames编著的《抗体工程》(第三版)。指导本科生荣获全国大学生生命科学竞赛二等奖、指导“大学生创新创业训练计划”国家级、省级和校级等项目。
工作及教育经历
2022/12至今,大连理工大学,生物工程学院,博士生导师
2018/12至今,大连理工大学,生物工程学院,副教授
2013/12-2018/11,大连理工大学,生命科学与技术学院,讲师
2013/08-2013/11,大连理工大学,生命科学与技术学院,师资博士后
2010/09-2012/10,美国匹兹堡大学医学部结构生物学系,联合培养博士
2006/09-2013/07,大连理工大学,生物化工专业,博士学位(保研)
2002/09-2006/07,大连理工大学,生物工程专业,学士学位